Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
On J, Natsumeda M, Takahashi H, Koyama A, Shibuma S, Shibata N, Watanabe J, Saito S, Kanemaru Y, Tsukamoto Y, Okada M, Ogura R, Eda T, Tada M, Shimizu H, Adachi JI, Mishima K, Nishikawa R, Kakita A, Oishi M. On J, et al. Among authors: kanemaru y. J Neurooncol. 2024 Jan;166(2):273-282. doi: 10.1007/s11060-023-04555-5. Epub 2024 Jan 16. J Neurooncol. 2024. PMID: 38227143
Diabetes in a Patient with Glycogen Storage Disease Type 1a.
Kanemaru Y, Harada N, Wada N, Yasuda T, Okamura E, Fujii T, Ogura M, Inagaki N. Kanemaru Y, et al. Intern Med. 2024 Aug 1;63(15):2153-2156. doi: 10.2169/internalmedicine.2766-23. Epub 2024 Jan 2. Intern Med. 2024. PMID: 38171878 Free PMC article.
SWI by 7T MR Imaging for the Microscopic Imaging Diagnosis of Astrocytic and Oligodendroglial Tumors.
Natsumeda M, Matsuzawa H, Watanabe M, Motohashi K, Gabdulkhaev R, Tsukamoto Y, Kanemaru Y, Watanabe J, Ogura R, Okada M, Kurabe S, Okamoto K, Kakita A, Igarashi H, Fujii Y. Natsumeda M, et al. Among authors: kanemaru y. AJNR Am J Neuroradiol. 2022 Nov;43(11):1575-1581. doi: 10.3174/ajnr.A7666. Epub 2022 Oct 13. AJNR Am J Neuroradiol. 2022. PMID: 36229164 Free PMC article.
Elucidating the multiple genetic alterations involved in the malignant transformation of a KRAS mutant neurenteric cyst. A case report.
Saito S, Natsumeda M, Sainouchi M, Takino T, Shibuya K, On J, Kanemaru Y, Ogura R, Okada M, Oishi M, Shimada Y, Wakai T, Okuda S, Ajioka Y, Kakita A, Fujii Y. Saito S, et al. Among authors: kanemaru y. Neuropathology. 2022 Dec;42(6):519-525. doi: 10.1111/neup.12822. Epub 2022 Sep 22. Neuropathology. 2022. PMID: 36146951
HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade Glioma.
Sasame J, Ikegaya N, Kawazu M, Natsumeda M, Hayashi T, Isoda M, Satomi K, Tomiyama A, Oshima A, Honma H, Miyake Y, Takabayashi K, Nakamura T, Ueno T, Matsushita Y, Iwashita H, Kanemaru Y, Murata H, Ryo A, Terashima K, Yamanaka S, Fujii Y, Mano H, Komori T, Ichimura K, Cahill DP, Wakimoto H, Yamamoto T, Tateishi K. Sasame J, et al. Among authors: kanemaru y. Clin Cancer Res. 2022 Jun 1;28(11):2425-2439. doi: 10.1158/1078-0432.CCR-21-3622. Clin Cancer Res. 2022. PMID: 35344043
Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with Temozolomide.
Eda T, Okada M, Ogura R, Tsukamoto Y, Kanemaru Y, Watanabe J, On J, Aoki H, Oishi M, Takei N, Fujii Y, Natsumeda M. Eda T, et al. Among authors: kanemaru y. Cancers (Basel). 2022 Feb 2;14(3):770. doi: 10.3390/cancers14030770. Cancers (Basel). 2022. PMID: 35159037 Free PMC article.
Development of chimeric receptor activator of nuclear factor-kappa B with glutathione S-transferase in the extracellular domain: Artificial switch in a membrane receptor.
Kawashima K, Hirota-Tsukimachi M, Toma T, Koga R, Iwamaru K, Kanemaru Y, Yanae M, Ahagon A, Nakamura Y, Anraku K, Tateishi H, Gohda J, Inoue JI, Otsuka M, Fujita M. Kawashima K, et al. Among authors: kanemaru y. Chem Biol Drug Des. 2022 Apr;99(4):573-584. doi: 10.1111/cbdd.14002. Epub 2021 Dec 19. Chem Biol Drug Des. 2022. PMID: 34882966
81 results